Integrating multimodal data for precise subtyping and prognostication in patients with pulmonary mucinous adenocarcinoma.

IF 2.1 4区 医学 Q4 ONCOLOGY
Translational cancer research Pub Date : 2026-09-30 Epub Date: 2026-08-13 DOI:10.21037/tcr-2026-1241
Weiwei Yang, Chen Chen, Lue Li, Zehao Chen, Ziyi Chen, Hanbo Le, Yongkui Zhang, Wangyu Zhu
{"title":"Integrating multimodal data for precise subtyping and prognostication in patients with pulmonary mucinous adenocarcinoma.","authors":"Weiwei Yang, Chen Chen, Lue Li, Zehao Chen, Ziyi Chen, Hanbo Le, Yongkui Zhang, Wangyu Zhu","doi":"10.21037/tcr-2026-1241","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pulmonary mucinous adenocarcinoma (PMA) represents a rare lung adenocarcinoma subtype, characterized by a lack of comprehensive pathological classification and prognostic factors. In this study, we propose a multimodal machine learning (ML) framework that integrates multiple data modalities to enhance PMA subtype classification and prognostic prediction.</p><p><strong>Methods: </strong>This retrospective study enrolled 175 primary PMA cases with details of demographic, histopathological, computed tomography (CT) imaging, and epithelial growth factor receptor (<i>EGFR</i>) mutation data. Least absolute shrinkage and selection operator (LASSO) regularized logistic regression model was utilized for histological classification, and Cox proportional hazards model was employed for survival prediction with internal validation.</p><p><strong>Results: </strong>Pure mucinous adenocarcinoma presented a higher prevalence of smaller radiographic or pathological tumor size, lower lobe localization, lower rates of lymph node metastasis and spread through air spaces (STAS), early pathological stage, carcinoembryonic antigen (CEA) ≤5 ng/mL, spiculated margin, Ki-67 low expression and lower frequency of <i>EGFR</i> exon 19 deletion (P=0.002, 0.003, <0.001, <0.001, 0.001, <0.001, 0.002, 0.03, 0.02, 0.001, respectively) compared to mix mucinous and mucin-secreting adenocarcinoma. The ML-derived nomogram achieved discriminative ability, with an area under the curve (AUC) of 0.792 in the training set and 0.687 in the validation set, and exhibited satisfactory calibration for the preoperative diagnosis of pure mucinous adenocarcinoma. Multivariate Cox modeling identified higher CEA levels, and <i>EGFR</i> exon 19 deletion as independent prognostic factors in PMA (P=0.04, 0.049, respectively). Moreover, Kaplan-Meier curves revealed significantly different outcomes between low- and high-risk groups stratified by the nomogram score (P<0.001).</p><p><strong>Conclusions: </strong>Pulmonary pure mucinous adenocarcinoma exhibited lower malignancy compared to the mixed mucinous and mucin-secreting type. The nomogram model developed and validated in this study exhibited promising efficacy in predicting histological subtype preoperatively and survival in patients with PMA, offering guidance for clinicians in diagnosis and prognosis prediction.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"15 9","pages":"708"},"PeriodicalIF":2.1000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13657839/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-2026-1241","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pulmonary mucinous adenocarcinoma (PMA) represents a rare lung adenocarcinoma subtype, characterized by a lack of comprehensive pathological classification and prognostic factors. In this study, we propose a multimodal machine learning (ML) framework that integrates multiple data modalities to enhance PMA subtype classification and prognostic prediction.

Methods: This retrospective study enrolled 175 primary PMA cases with details of demographic, histopathological, computed tomography (CT) imaging, and epithelial growth factor receptor (EGFR) mutation data. Least absolute shrinkage and selection operator (LASSO) regularized logistic regression model was utilized for histological classification, and Cox proportional hazards model was employed for survival prediction with internal validation.

Results: Pure mucinous adenocarcinoma presented a higher prevalence of smaller radiographic or pathological tumor size, lower lobe localization, lower rates of lymph node metastasis and spread through air spaces (STAS), early pathological stage, carcinoembryonic antigen (CEA) ≤5 ng/mL, spiculated margin, Ki-67 low expression and lower frequency of EGFR exon 19 deletion (P=0.002, 0.003, <0.001, <0.001, 0.001, <0.001, 0.002, 0.03, 0.02, 0.001, respectively) compared to mix mucinous and mucin-secreting adenocarcinoma. The ML-derived nomogram achieved discriminative ability, with an area under the curve (AUC) of 0.792 in the training set and 0.687 in the validation set, and exhibited satisfactory calibration for the preoperative diagnosis of pure mucinous adenocarcinoma. Multivariate Cox modeling identified higher CEA levels, and EGFR exon 19 deletion as independent prognostic factors in PMA (P=0.04, 0.049, respectively). Moreover, Kaplan-Meier curves revealed significantly different outcomes between low- and high-risk groups stratified by the nomogram score (P<0.001).

Conclusions: Pulmonary pure mucinous adenocarcinoma exhibited lower malignancy compared to the mixed mucinous and mucin-secreting type. The nomogram model developed and validated in this study exhibited promising efficacy in predicting histological subtype preoperatively and survival in patients with PMA, offering guidance for clinicians in diagnosis and prognosis prediction.

整合肺粘液腺癌患者精确亚型分型和预后的多模式数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
252
期刊介绍: Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书